← Back to Search

Extended Antibiotics for Penile Prosthesis Infection (CUPID Trial)

Phase < 1
Waitlist Available
Led By Sarah Faris, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
History of cystitis caused by Tuberculosis
Systemic neuromuscular disease known to affect the lower urinary tract such as Spinal Cord Injury, Multiple Sclerosis or other condition leading to neurogenic bladder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether 6 extra days of antibiotics can lower the risk of infection for men getting a penile prosthesis.

Who is the study for?
This trial is for males aged 35-90 with erectile dysfunction who are getting a specific penile prosthesis (AMS 700) and haven't used antibiotics in the last week. It's not for those with prior prostheses, urinary tract foreign bodies, urethral strictures, tuberculosis-related cystitis, recent chemotherapy, bladder surgery history or systemic neuromuscular diseases.
What is being tested?
The study tests if taking oral antibiotics (Doxycycline, Augmentin, Bactrim or Ciprofloxacin) for an extra six days after implanting a penile prosthesis can reduce infection risk. Participants will receive one of these antibiotics to see which is most effective.
What are the potential side effects?
Possible side effects from the antibiotics may include stomach upset like nausea and diarrhea; allergic reactions such as rashes; yeast infections; and rarely more serious issues like tendon problems or nerve damage.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had bladder inflammation due to Tuberculosis.
Select...
I have a condition like MS that affects bladder control.
Select...
I have or had a painful narrowing of the urethra.
Select...
I have not taken antibiotics in the last week and do not need them now.
Select...
I have had bladder enlargement or removal surgery.
Select...
I am currently on Cytoxan or immunosuppressive chemotherapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Additional 6 days of oral antibiotics after Penile prothesis placement does not decrease the risk of device infection leading to surgical intervention
Secondary study objectives
Additional 6 days of oral antibiotics after Penile prosthesis placement does not decrease the risk of superficial tissue infections after penile prothesis implantation.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: No post-operative oral antibioticsActive Control1 Intervention
Patients will only receive 24hr of IV peri-operative antibiotics
Group II: 6 days of oral antibioticsActive Control4 Interventions
Patients will receive 24hr of IV peri-operative antibiotics and then 6 days of oral antibiotics

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,053 Previous Clinical Trials
758,274 Total Patients Enrolled
1 Trials studying Erectile Dysfunction
1 Patients Enrolled for Erectile Dysfunction
Loyola UniversityOTHER
160 Previous Clinical Trials
30,619 Total Patients Enrolled
Sarah Faris, MDPrincipal InvestigatorUniversity of Chicago Department of Surgery

Media Library

6 days of oral antibiotics Clinical Trial Eligibility Overview. Trial Name: NCT05100654 — Phase < 1
Erectile Dysfunction Research Study Groups: No post-operative oral antibiotics, 6 days of oral antibiotics
Erectile Dysfunction Clinical Trial 2023: 6 days of oral antibiotics Highlights & Side Effects. Trial Name: NCT05100654 — Phase < 1
6 days of oral antibiotics 2023 Treatment Timeline for Medical Study. Trial Name: NCT05100654 — Phase < 1
~25 spots leftby Dec 2024